>>> In fact, even European pharmaceutical companies make most of their revenue from sales in the US, not Europe. (This is why the US funds over 50% of R&D for t

>>> In fact, even European pharmaceutical companies make most of their revenue from sales in the US, not Europe. (This is why the US funds over 50% of R&D for the entire world, even though it only has 300 million people, and many of the largest pharmaceutical companies are based in Europe, not the US). This just isn't true. Take Norvatis for example, one of the biggest pharmaceutical companies in the world. The US makes 35% of their revenue and Europe another 35%, with the rest of the world sharing the rest. [0] I wouldn't call that "most of their revenue". In fact, I don't see anything out of the ordinary about revenue gained per customer, given the size and purchasing power of the US. There's little evidence to suggest that higher drug prices actually help the drug companies. [0] https://www.statista.com/statistics/294631/novartis-revenue-by-region/ https://www.statista.com/statistics/294631/novartis-revenue-...